Can the DIO2 rs225014 CT variant reduce local T4-to-T3 signaling and cause fatigue and cold intolerance?

The DIO2 rs225014 (Thr92Ala) polymorphism is a genetic variant that alters the intracellular activation of thyroid hormone, decoupling local tissue thyroid signaling from systemic hormone levels.

Molecular and cellular mechanisms

• Impaired proteostasis and trafficking: The rs225014 variant causes the mutant type II deiodinase (D2) protein to accumulate abnormally in the trans-Golgi apparatus instead of trafficking correctly, triggering endoplasmic reticulum (ER) stress and the unfolded protein response (UPR).
• Decreased catalytic efficiency: Although cell-free systems report normal kinetics, intact-cell models confirm that altered cellular trafficking and proteostasis defects significantly degrade the net catalytic conversion of inactive thyroxine (T4) to active triiodothyronine (T3).
• Intermediate heterozygous impact: In heterozygous CT (Thr/Ala) individuals, this pathology results in intermediate deiodinase efficiency, leading to a localized, tissue-specific reduction in intracellular T3 supply.

Clinical evidence and tissue-level symptoms

• Normal systemic markers: Systemic thyroid panels—specifically thyroid-stimulating hormone (TSH), free T4, and free T3—frequently remain within normal reference ranges because central pituitary feedback and type I deiodinase (DIO1) compensation preserve circulating homeostasis.
• Local hypothyroidism: Despite normal blood chemistry, target tissues such as skeletal muscle and the brain experience local T3 deprivation. This tissue-specific deficit directly triggers hypothyroid-like symptoms, including persistent fatigue, cognitive sluggishness, and cold intolerance.
• Therapeutic implications: Because standard serum assays do not reflect intracellular T3 concentrations, carriers of this variant often experience unresolved symptoms on standard T4 monotherapy but demonstrate preferential clinical improvement when transitioned to combination T4/T3 therapeutic regimens.

Bottom line

• The DIO2 rs225014 CT variant impairs local T4-to-T3 conversion via D2 cellular trafficking defects and ER stress, causing localized tissue hypothyroidism. Consequently, patients can experience classic hypothyroid symptoms like fatigue and cold intolerance even when standard circulating thyroid hormone levels are entirely normal.